Published in Lab Business Week, May 28th, 2006
Net earnings for the first quarter of 2006 increased 18.5% to $295.7 million, or $0.95 per share on a diluted basis, compared to $249.5 million, or $0.80 per share for the first quarter of 2005. Earnings per share in the first quarter of 2006 were reduced by approximately $0.07 per share due to the expensing of share-based compensation expense as a result of the implementation of Statement of Financial Accounting Standards (SFAS) 123. If SFAS 123 had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.